ResMed’s Global Sleep Surveys Reveal What’s Keeping Us Up at Night; Aim to Bring Awareness to the State of Sleep Health for World Sleep Day
14 mars 2022 09h00 HE
|
ResMed Inc.
Surveys found pandemic-related stress and anxiety are the most cited reasons keeping people up at nightQuality and quantity of sleep have benefitted from remote working, and many are concerned waking...
ResMed Announces Participation in the Oppenheimer 32nd Annual Healthcare Conference
10 mars 2022 09h00 HE
|
ResMed Inc.
SAN DIEGO, March 10, 2022 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced Rob Douglas, president and chief operating officer, will present at the Oppenheimer 32nd Annual Healthcare...
ResMed Announces Participation in the Citi Healthcare Conference
16 févr. 2022 09h00 HE
|
ResMed Inc.
SAN DIEGO, Feb. 16, 2022 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced Mick Farrell, chief executive officer, will participate in a virtual fireside chat at the Citi Healthcare...
ResMed Welcomes Urvashi Tyagi as New Chief Technology Officer
01 févr. 2022 09h00 HE
|
ResMed Inc.
Tyagi brings over 25 years’ IT and leadership experience from ADP, American Express, Amazon, Microsoft, and IBMCurrent CTO and SaaS President Bobby Ghoshal now transitions to SaaS full-time SAN...
ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2022
27 janv. 2022 16h05 HE
|
ResMed Inc.
Year-over-year revenue grows 12%, operating profit up 12%, non-GAAP operating profit up 5% Note: A webcast of ResMed’s conference call will be available at 4:30 p.m. ET today at...
ResMed to Report Second Quarter Fiscal 2022 Earnings on January 27, 2022
06 janv. 2022 16h05 HE
|
ResMed Inc.
SAN DIEGO, Jan. 06, 2022 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced it plans to release financial and operational results for the second quarter of fiscal year 2022 on...
ResMed Announces Participation in the 40th Annual J.P. Morgan Healthcare Conference
03 janv. 2022 09h00 HE
|
ResMed Inc.
SAN DIEGO, Jan. 03, 2022 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced Mick Farrell, chief executive officer, will present at the 40th Annual J.P. Morgan Healthcare Conference on...
ResMed Announces Participation in the Goldman Sachs 14th Annual Healthcare CEOs Unscripted Conference
30 déc. 2021 09h00 HE
|
ResMed Inc.
SAN DIEGO, Dec. 30, 2021 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced Mick Farrell, chief executive officer, will present at the Goldman Sachs 14th Annual Healthcare CEOs...
ResMed Elects Health Tech Leaders Desney Tan and John Hernandez to Its Board of Directors
19 nov. 2021 09h00 HE
|
ResMed Inc.
Tan is vice president and managing director of Microsoft’s Health and Life Science R&D Hernandez is Google’s head of clinical research, health economics, and outcomes researchBoth leaders’ digital...
ResMed Announces Participation in the Credit Suisse 30th Annual Healthcare Conference
03 nov. 2021 09h00 HE
|
ResMed Inc.
SAN DIEGO, Nov. 03, 2021 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced Mick Farrell, chief executive officer, will participate in a virtual fireside chat at the Credit Suisse 30th...